Published in J Nucl Med on October 01, 1975
Treatment of hyperthyroidism with sodium iodide I-131. JAMA (1966) 1.93
Scintigraphic localization of pheochromocytoma. N Engl J Med (1981) 1.88
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med (1985) 1.72
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med (1976) 1.26
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med (1987) 1.22
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Salivary gland accumulation of meta-[131I]iodobenzylguanidine. J Nucl Med (1984) 1.21
Management of severe hypercalcemia caused by primary hyperparathyroidism. Arch Surg (1978) 1.20
Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol (1988) 1.20
Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet (1974) 1.19
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med (1987) 1.18
Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol (1979) 1.17
Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131. JAMA (1970) 1.16
Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med (1985) 1.14
MEN I pancreas: a histological and immunohistochemical study. World J Surg (1984) 1.12
Nasopharyngeal carcinomas in children. Arch Surg (1967) 1.12
New horizons for therapeutic nuclear medicine in 1981. J Nucl Med (1981) 1.11
Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med (1984) 1.11
Sarcoidosis, hypercalcemia and primary hyperparathyroidism. The vicissitudes of diagnosis. Am J Surg (1981) 1.11
Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer (1972) 1.11
Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol (1993) 1.07
Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension (1997) 1.07
Multiple adenomas of the parathyroids: do they exist? Arch Surg (1979) 1.07
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. J Clin Endocrinol Metab (1977) 1.06
Dental Changes in Rats Consuming a Diet Poor in Inorganic Salts. Yale J Biol Med (1936) 1.06
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med (1981) 1.06
Thyroid carcinoma: current controversies. Curr Probl Surg (1978) 1.04
Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis. World J Surg (1992) 1.01
Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int (1989) 1.01
Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. Radiology (1985) 1.01
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med (1983) 1.00
Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol (1992) 1.00
Radiation dosimetry of 131I-19-iodocholesterol. J Nucl Med (1973) 1.00
Visualizing human malignant melanoma and metastases. Use of chloroquine analog tagged with iodine 125. JAMA (1968) 1.00
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med (1984) 0.99
Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology (1989) 0.99
Adrenal scintigraphy. Semin Nucl Med (1978) 0.99
Scanning electron microscopy of microcorrosion casts; intracranial and abdominal microvasculature in domestic animals. Am J Anat (1978) 0.98
Thyroidectomy for hyperthyroidism. Arch Surg (1970) 0.98
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med (1981) 0.98
The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med (1978) 0.97
The analysis of blood diseases with the electron microprobe. Blood (1969) 0.97
The Limulus test for in vitro pyrogen detection. Am J Hosp Pharm (1974) 0.96
Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension (1983) 0.95
The scintigraphic imaging of endocrine organs. Endocr Rev (1984) 0.95
Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol (1993) 0.95
Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg (1998) 0.94
Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension (1998) 0.94
Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension (1992) 0.94
Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension (1998) 0.93
Primary mucinous adenocarcinoma of thyroid gland. Cancer (1976) 0.93
Correlation of brain scan image and area counting after scanning with tumor pathology. J Nucl Med (1966) 0.92
Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol (1979) 0.92
Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension (1993) 0.92
Small cell tumors of the thyroid. A clinicopathologic study. Cancer (1971) 0.92
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. J Clin Endocrinol Metab (1998) 0.91
Germinal neoplasms of the central nervous system. Arch Surg (1966) 0.91
Diagnosis of adrenal disease by visualization of human adrenal glands with 131 I-19-iodocholesterol. N Engl J Med (1971) 0.91
Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules. Surg Clin North Am (1979) 0.90
Autoimmune thyroid disease: immunological, pathological, and clinical aspects. Crit Rev Clin Lab Sci (1988) 0.90
Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med (1983) 0.89
Free thyroxine in serum in relation to thyroid function. JAMA (1968) 0.89
Relationship of iodine to "lymphocytic goiters". Arch Surg (1969) 0.89
The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med (1982) 0.89
Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II. Surgery (1977) 0.89
Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med (1992) 0.89
Childhood thyroid carcinoma. Arch Surg (1971) 0.89
Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med (1985) 0.88
Radiocholesterol adrenal images for the localization of pheochromocytoma. Surg Gynecol Obstet (1974) 0.88
Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med (1982) 0.87
Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens (2000) 0.87
Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization. Clin Endocrinol (Oxf) (1984) 0.87
Adrenal imaging with radioiodocholesterol in the diagnosis of adrenal disorders. Adv Intern Med (1974) 0.87
Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats. J Am Soc Nephrol (1994) 0.87
Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med (1984) 0.86
Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg (1982) 0.86
Tumor localizing agents. IX. Radioiodinated cholesterol. Steroids (1970) 0.86
Interaction of the prostaglandin and renin-angiotensin systems in isolated rat glomeruli. Am J Physiol (1980) 0.86
Beta-adrenoceptor-stimulated renin release is blunted in old rats. J Am Soc Nephrol (1998) 0.86
Renal morphology of freshwater trout. Am J Anat (1975) 0.86
Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. Am J Obstet Gynecol (2001) 0.85
Primary aldosteronism. Photoscanning of tumors after administration of 131 I-19-iodocholesterol. Arch Intern Med (1972) 0.85
A new and superior adrenal scanning agent, NP-59. J Nucl Med (1975) 0.85
Effects of aging and alterations in dietary sodium intake on total nitric oxide production. Am J Kidney Dis (2001) 0.85
Hydrofluoric acid burns. A report of a case and review of the literature. Arch Dermatol (1979) 0.85
Nuclear pharmacy, Part I: Emergence of the specialty of nuclear pharmacy. J Nucl Med Technol (2000) 0.85
The effect of aprotinin (a serine protease inhibitor) on renal function and renin release. Hypertension (1984) 0.84
Dog thyroiditis: occurrence and similarity to Hashimoto's struma. Endocrinology (1968) 0.84
Locating pheochromocytomas by scintigraphy using 131I-metaiodobenzylguanidine. CA Cancer J Clin (1984) 0.84
Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases. Arch Surg (1974) 0.84
Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication. J Nucl Med (1984) 0.84